Leash Biosciences is an AI-driven drug discovery platform focused on accelerating the creation of new medicines. It builds large-scale biological datasets by testing protein–molecule interactions and uses machine learning to design better drug candidates. The main goal is to reduce the time and cost of finding effective treatments by combining lab experiments with AI-powered molecular design.
Platforms:
Large-scale protein–molecule interaction dataset for training AI models
AI-assisted molecular design to create new potential drug compounds
High-throughput lab screening to test millions of chemical interactions
Machine learning models trained on billions of biochemical data points
Iterative discovery loop combining experiments and AI predictions
Focus on oncology and complex disease target research
Scalable software system for rapid drug candidate generation and refinement
